TNF and inflammatory bowel disease: However, the few existing clinical studies have produced controversial results; some of them reported neutral or marginally beneficial impact of anti-TNF agents on MASLD, while others reported higher prevalence of MASLD after treatment, potentially associated with weight gain and an increase in visceral adiposity after achieving remission of IBD [25,26,27].